DBX4:F:F-Xtrackers - MSCI EM Europe Middle East & Africa Swap UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 33.425

Change

-0.04 (-0.12)%

Market Cap

N/A

Volume

90.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

N/A

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.23 (+0.45%)

USD 114.13B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 106.46B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.29 (+0.51%)

USD 100.12B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 63.18B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.02 (+0.02%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

+0.01 (+0.00%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+3.15 (+1.30%)

USD 51.11B
XJSE:F Xtrackers II - Japan Governmen..

+0.01 (+0.14%)

USD 43.12B
0ZC:F Zscaler Inc

-1.12 (-0.61%)

USD 37.92B

ETFs Containing DBX4:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.11% 53% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.11% 53% F 52% F
Trailing 12 Months  
Capital Gain 19.55% 73% C 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.55% 69% C- 58% F
Trailing 5 Years  
Capital Gain 20.60% 51% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.60% 50% F 41% F
Average Annual (5 Year Horizon)  
Capital Gain 7.51% 60% D- 59% D-
Dividend Return 7.51% 58% F 52% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.52% 54% F 85% B
Risk Adjusted Return 60.02% 63% D 73% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike